Przybylski, P.; Lewińska, A.; Rzeszutek, I.; Błoniarz, D.; Moskal, A.; Betlej, G.; Deręgowska, A.; Cybularczyk-Cecotka, M.; Szmatoła, T.; Litwinienko, G.;
et al. Mutation Status and Glucose Availability Affect the Response to Mitochondria-Targeted Quercetin Derivative in Breast Cancer Cells. Cancers 2023, 15, 5614.
https://doi.org/10.3390/cancers15235614
AMA Style
Przybylski P, Lewińska A, Rzeszutek I, Błoniarz D, Moskal A, Betlej G, Deręgowska A, Cybularczyk-Cecotka M, Szmatoła T, Litwinienko G,
et al. Mutation Status and Glucose Availability Affect the Response to Mitochondria-Targeted Quercetin Derivative in Breast Cancer Cells. Cancers. 2023; 15(23):5614.
https://doi.org/10.3390/cancers15235614
Chicago/Turabian Style
Przybylski, Paweł, Anna Lewińska, Iwona Rzeszutek, Dominika Błoniarz, Aleksandra Moskal, Gabriela Betlej, Anna Deręgowska, Martyna Cybularczyk-Cecotka, Tomasz Szmatoła, Grzegorz Litwinienko,
and et al. 2023. "Mutation Status and Glucose Availability Affect the Response to Mitochondria-Targeted Quercetin Derivative in Breast Cancer Cells" Cancers 15, no. 23: 5614.
https://doi.org/10.3390/cancers15235614
APA Style
Przybylski, P., Lewińska, A., Rzeszutek, I., Błoniarz, D., Moskal, A., Betlej, G., Deręgowska, A., Cybularczyk-Cecotka, M., Szmatoła, T., Litwinienko, G., & Wnuk, M.
(2023). Mutation Status and Glucose Availability Affect the Response to Mitochondria-Targeted Quercetin Derivative in Breast Cancer Cells. Cancers, 15(23), 5614.
https://doi.org/10.3390/cancers15235614
